| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/14/2006 | CA2598613A1 Defibrotide and/or oligodeoxyribonucleotides for treating angiogenesis-dependent tumors |
| 09/14/2006 | CA2598072A1 Oligodeoxyribonucleotides of 4000-10000 dalton for treating tumors |
| 09/14/2006 | CA2597485A1 Methods and compositions for modulating tweak and fn14 activity |
| 09/14/2006 | CA2597255A1 Natural ligand of g protein coupled receptor rcc356 and uses thereof |
| 09/14/2006 | CA2597244A1 Methods and compositions for the treatment of cancer |
| 09/13/2006 | EP1700921A2 Regulation of a human asparagine-hydroxylase |
| 09/13/2006 | EP1700867A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/13/2006 | EP1700603A2 Immunostimulatory nucleic acids |
| 09/13/2006 | EP1700598A1 Anti-proliferative combination therapy comprising satraplatin or JM118 and docetaxel |
| 09/13/2006 | EP1699822A2 Il-7 fusion proteins with antibody portions, their preparation and their use |
| 09/13/2006 | EP1699806A1 Glycosaminoglycan (gag) mimetics |
| 09/13/2006 | EP1699798A2 Di-substituted pyrrolotriazine compounds |
| 09/13/2006 | EP1699797A1 Pyrrolotriazine compounds as kinase inhibitors |
| 09/13/2006 | EP1699796A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 09/13/2006 | EP1699792A1 Piperazine, 1,4¨diazepane, 1,4¨diazocane, and 1,5¨diazocane fused imidazo ring compounds |
| 09/13/2006 | EP1699782A1 Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 09/13/2006 | EP1699485A2 Anti-hydroxylase antibodies and uses thereof |
| 09/13/2006 | EP1699480A1 Allogeneic tumor therapeutic agent |
| 09/13/2006 | EP1699472A1 Pharmaceutical active agent against breast cancer |
| 09/13/2006 | EP1699470A2 Biological active blood serum obtained by electrostimulation |
| 09/13/2006 | EP1699463A1 Pharmaceutical composition for treating and preventing cancer comprising cinnamoni cortex extract and zizyphi fructus extract |
| 09/13/2006 | EP1699462A1 Reduction of toxicity of multi-targeting antifolates |
| 09/13/2006 | EP1699460A2 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 09/13/2006 | EP1699421A2 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 09/13/2006 | EP1664033A4 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof |
| 09/13/2006 | EP1562610B1 Combination therapy with gemcitabine and zd6126 |
| 09/13/2006 | EP1513942B1 Galactosyl isomalt, method for production and use thereof |
| 09/13/2006 | EP1511752B1 Camptothecins with a modified lactone ring |
| 09/13/2006 | EP1497274B1 Terphenyl derivatives, preparation thereof, compositions containing same |
| 09/13/2006 | EP1442050B1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 09/13/2006 | EP1414813B1 1,2,4-trioxolane antimalarials |
| 09/13/2006 | EP1414465B1 Use of inhibitors of progesterone receptor for treating steroid resistant breast cancer |
| 09/13/2006 | EP1406869B1 Taxol enhancer compounds |
| 09/13/2006 | EP1389206B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/13/2006 | EP1345604B1 Use of a alpha-halogen-acryloyl distamycin derivate for the preparation of a medicament for the treatment of cancer |
| 09/13/2006 | EP1335922B1 Process for preparing 4'-demethyl-4'-O-substituted-1-deoxypodophyllotoxin derivatives and geometric isomers thereof and anti-cancer composition comprising the same |
| 09/13/2006 | EP1305635B1 Methods to identify compounds that modulate rage |
| 09/13/2006 | EP1282643B1 Anti-inflammatory compounds and uses thereof |
| 09/13/2006 | EP1267843B1 System for transporting active substances in a biological system |
| 09/13/2006 | EP1246617B1 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of ovarian cancer |
| 09/13/2006 | EP1244621B1 Nitrile derivatives as cathepsin k inhibitors |
| 09/13/2006 | EP1237888B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/13/2006 | EP1230215B1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 09/13/2006 | EP1229938B1 Potentiation of the activity of sn-38 prodrugs |
| 09/13/2006 | EP1224288B1 Processed human chemokine phc-1 |
| 09/13/2006 | EP1218358B1 Therapeutic quinazoline compounds |
| 09/13/2006 | EP1200067B1 Method for the preparation of microparticles comprising biological material |
| 09/13/2006 | EP1196579B1 Tryptase inhibitor |
| 09/13/2006 | EP1183050B1 Method for producing an injectable medicament preparation |
| 09/13/2006 | EP1163272B1 Antibodies specific for cyp1b1 |
| 09/13/2006 | EP1095062B1 Method of treating disorders by modulating the interaction of natural killer receptors on t cells with their respective ligands |
| 09/13/2006 | EP1087951B9 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 09/13/2006 | EP1007656B1 Modified protein kinase a-specific hybrid oligonucleotide in combination with paclitaxol and methods of their use |
| 09/13/2006 | CN1832969A Etherified carbamate functional copolymers of isobutylene type monomers, and their use in curable compositions |
| 09/13/2006 | CN1832956A Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same |
| 09/13/2006 | CN1832757A Use of a combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer |
| 09/13/2006 | CN1832747A Combinations comprising staurosporines |
| 09/13/2006 | CN1832743A Dosage forms comprising ag013736 |
| 09/13/2006 | CN1832728A Process for producing drug ultramicroparticle and apparatus therefor |
| 09/13/2006 | CN1831121A Method for structuring hybridoma cell system for anti-human monoclonal antibody of hepatitis B virus and its application |
| 09/13/2006 | CN1831015A Process for extracting fructus ligustri lucidi and Radixa stragali polysaccharide, the products and application thereof |
| 09/13/2006 | CN1831011A Antigen epitope of beta2-microglobulin and its application |
| 09/13/2006 | CN1831007A Sythesis of sugar substituted MAVgn, 99Tcm and 186Re tag and application of said tag |
| 09/13/2006 | CN1831006A Sugar substituted MAAGn synthesis, 99Tcm or 186Rc tag and tag in application of radiation medicine for treating tumor |
| 09/13/2006 | CN1831005A Synthesis of sugar substituted MAGn, and 99Tcm or 186 Re tag and tag, application for tumor medicine thereof |
| 09/13/2006 | CN1831002A Synthesis of novel adenosine polypeptide compounds, and 99Tcm, 186Re tag and tag, and application in tumor treating medicines |
| 09/13/2006 | CN1831000A Synthesis of novel imurel substituted peptide compounds, and 99Tcm, 186 Re tagging, and tumor medicine, anoxic imaging agent |
| 09/13/2006 | CN1830994A Derivative of protopanoxatriol, prepn. method and application thereof |
| 09/13/2006 | CN1830989A Novel adenine polypeptide compounds synthesis and 99Tcm, 186Re tagging and the tag used in tumor and anoxic visulization |
| 09/13/2006 | CN1830983A Dihydroporphine E6 zinc compound photosensitizer and its preparation method and application |
| 09/13/2006 | CN1830979A Quinazolin allkaloids compound, prepn. method and use thereof |
| 09/13/2006 | CN1830973A 9-anthrone lactone compounds, preparing method and use thereof |
| 09/13/2006 | CN1830964A 4-Substituting anilino-3-nitroquinoline compounds, prepn. method and use thereof |
| 09/13/2006 | CN1830960A 10-phenyl hydroisoindolone type compounds, prepn. method and use thereof |
| 09/13/2006 | CN1830489A Tumour polypeptide vaccine based on gastrin release peptide |
| 09/13/2006 | CN1830487A Blood vessel formation inhibitor IIM3 and its preparation method and application |
| 09/13/2006 | CN1830486A Application of pumpkin protein in preparation of medicine |
| 09/13/2006 | CN1830444A Preparation method of Sophora flavescems injection |
| 09/13/2006 | CN1830428A Sodium ferulate injection and its preparation method |
| 09/13/2006 | CN1830329A Acid diminating foxin eliminating anticancer traditional Chinese medicine tea and its preparation method |
| 09/13/2006 | CN1830313A SOD cordyceps sinensis regulating water |
| 09/13/2006 | CN1275041C Prognostic indicator |
| 09/13/2006 | CN1274829C Anti EB virus resulted tumour polypeptide, and its use and preparing method |
| 09/13/2006 | CN1274823C Production of human interleukin 288 and recombined IL-288 engineering bacteria |
| 09/13/2006 | CN1274821C Modular transport systems for molecular substances and production and use thereof |
| 09/13/2006 | CN1274767C Process for extracting lycopene from false seed peel of balsam pear seed |
| 09/13/2006 | CN1274713C Inhibitors of kallikrein |
| 09/13/2006 | CN1274694C Lanthanum amino acid complex and its preparing process and application |
| 09/13/2006 | CN1274689C Plant extract and its application |
| 09/13/2006 | CN1274683C Ketone compound and its preparation method and application |
| 09/13/2006 | CN1274366C Medicinal nano carbon microsphere and its application for preparing medicine to treat cancer |
| 09/13/2006 | CN1274358C Specific medicine for treating cancer and preparing process |
| 09/13/2006 | CN1274355C Chinese medicine composition for treating cancer |
| 09/13/2006 | CN1274303C Use of compound and its derivatives in preparing medicine for treating cancer |
| 09/13/2006 | CN1274300C Combination of medication in use for improving dissolution of curcumin and bioavailability as well as preparation method |
| 09/13/2006 | CN1274299C Doxy rhodol magnetic microglobule and its making method |
| 09/12/2006 | US7105695 Anticarcinogenic agents formed by phosphorylation |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105670 Intermediates useful in the preparation of diaminothiazoles |
| 09/12/2006 | US7105669 Quinazoline derivatives |